fenfluramine

FDA Drug Profile — Fintepla

Drug Details

Generic Name
fenfluramine
Brand Names
Fintepla
Application Number
NDA212102
Sponsor
UCB, Inc.
NDC Codes
1
Dosage Forms
SOLUTION
Routes
ORAL
Active Ingredients
FENFLURAMINE

Indications and Usage

1 INDICATIONS AND USAGE FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older. FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older. ( 1 )